Search
Last update: : 13.10.2025
Enantioselective Total Syntheses of (+)-Kobusine, (+)-Spirasine IX and the Purported Structure of (+)-Orgetine: Strategic Use of C–H Bonds Deng M.; Wu F.; Liu T.; Jiang Z.; Luo T. J. Am. Chem. Soc.…
DocumentLast update: : 13.10.2025
Enantioselective Total Syntheses of (+)-Kobusine, (+)-Spirasine IX and the Purported Structure of (+)-Orgetine: Strategic Use of C–H Bonds Deng M.; Wu F.; Liu T.; Jiang Z.; Luo T. J. Am. Chem. Soc.…
DocumentLast update: : 10.10.2025
Tumors are not a comfortable place to live: oxygen deficiency, nutrient scarcity, and the accumulation of sometimes harmful metabolic products constantly stress cancer cells. A research team from the…
Press releaseLast update: : 09.10.2025
Until today, the aggressiveness of prostate cancer has been assessed primarily using the Gleason grading system—an analysis of cancer tissue in a pathology laboratory that is highly subjective. An…
Press releaseLast update: : 08.10.2025
Our Research Our department is dedicated to addressing critical challenges in cancer immunotherapy, focusing on three key research areas: Targeted RNA Delivery: Investigating the potential of…
Last update: : 08.10.2025
We are an interdisciplinary and international team jointly hosted at the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) in Heidelberg. In our…
Last update: : 08.10.2025
Our Research How does our genetic background shape phenotypic traits or cause cancer? How are genetic and environmental factors integrated at different molecular layers, and how variable are…
Last update: : 07.10.2025
Leonie Boland E130 Ph.D Student Leonie Boland completed both her Bachelor’s degree in Mathematics and her Master’s degree in Scientific Computing at Heidelberg University. During the later stages of…
Last update: : 07.10.2025
Prof. Dr. med. Michael Schlander +49 6221 42 1910 +49 6221 42 1919 M010 Head of Division Professional Background Michael Schlander is a full professor of health economics at the University of…